SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following its strong earnings beat and robust guidance, yet community discussion is sharply divided between those celebrating continued AI growth and others citing "buy on rumor, sell on news" dynamics, market manipulation, and the impact of IV crush on options traders.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending after its recent earnings report, which, despite beating revenue and EPS, triggered a significant sell-off due to light Q1 guidance. This has ignited intense debate among investors, with many seeing an oversold buying opportunity given solid fundamentals and buybacks, while others voice concerns over long-term competitive pressures and AI disruption.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending after reporting strong Q4 earnings and announcing a massive $50 billion share buyback, yet its shares dipped post-announcement, sparking community debate over AI's disruptive potential for the SaaS sector and criticisms of leadership, despite many seeing the valuation as a buying opportunity.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as shareholders react to a mixed Q4 earnings report and CEO Doug Ingram's planned retirement, fueling fervent debate over the company's valuation and ongoing regulatory challenges amidst widespread frustration regarding stock performance and hopes for pipeline catalysts and a potential acquisition.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai ($AI) is trending following a deeply disappointing earnings report, which revealed significant revenue contraction and wider losses, fueling widespread community frustration and bearish sentiment. Discussions highlight the company's stark underperformance compared to the broader AI sector, with some optimists still eyeing 'oversold' conditions despite the negative news.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending after reporting a strong Q4 revenue beat and securing a spot on the Missile Defense Agency's SHIELD IDIQ contract, fueling optimism for growth and a potential short squeeze, even as concerns about its high valuation, dilution, and recent short report claims persist among the community.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is experiencing a significant post-earnings decline despite reporting strong growth and announcing a $200M OpenAI partnership. The community is actively debating whether this reflects market manipulation, an oversold condition, or a broader re-evaluation of software stocks amidst concerns about AI's potential to disrupt traditional data warehousing models.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending after an earnings report underscored continued delays in high-volume smartphone battery qualification and revenue, prompting significant community frustration and scrutiny over management and production yields. Nevertheless, some investors remain optimistic, highlighting the company's substantial cash reserves, a newly authorized share repurchase program, recent manufacturing leadership hires, and nascent demand from smart eyewear applications as potential drivers.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to widespread community discussion surrounding recent political rhetoric from a State of the Union speech, focusing on its economic claims and the resulting polarization, while also anticipating key NVIDIA earnings for broader market direction.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Strong Q4 earnings, featuring a significant EPS beat and a profitable combined ratio, are fueling discussion for Root Inc., coupled with new data partnerships with Toyota and Kikoff. The community is actively debating the stock's undervaluation and high short interest in anticipation of accelerated growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Hold" by Brokerages

Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have been given an average rating of "Hold" by the five ratings firms that are covering the firm, Marketbeat reports. One equities...

Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at Zacks Research

Zacks Research raised shares of Eton Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Thursday...

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from Brokerages

Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are covering the company, Marketbeat reports. Two equities...

Eton Pharmaceuticals (NASDAQ:ETON) Downgraded by Wall Street Zen to Hold

Wall Street Zen downgraded shares of Eton Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Saturday...

What is HC Wainwright's Estimate for ETON FY2025 Earnings?

Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Investment analysts at HC Wainwright cut their FY2025 earnings per share estimates for Eton Pharmaceuticals in a research report issued on...

Q4 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst

Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Research analysts at HC Wainwright cut their Q4 2026 EPS estimates for Eton Pharmaceuticals in a note issued to investors on Tuesday, December...

Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON

Divisadero Street Capital Management LP acquired a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F...

Geode Capital Management LLC Has $8.45 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON

Geode Capital Management LLC increased its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 98.8% in the 2nd quarter, according to the company in its most recent filing...

Diametric Capital LP Increases Stock Holdings in Eton Pharmaceuticals, Inc. $ETON

Diametric Capital LP lifted its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 333.0% in the 2nd quarter, according to its most recent filing with the Securities...

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Consensus Rating of "Hold" from Analysts

Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have received a consensus recommendation of "Hold" from the five research firms that are presently covering the stock...

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

The FDA has granted approval for DESMODA™ oral solution, a new ready-to-use liquid medicine designed to treat central diabetes insipidus in children and adults.

Despite the positive FDA approval, the stock experienced a significant trading halt followed by unexpected price declines, puzzling traders and fueling 'sell the news' discussions.

Traders are closely watching for a potential short squeeze, noting an increase in short interest by 5.62% and a Fintel squeeze score of 81.22.

Current Price	$17.52
Prev Close	$18.28
Open	$18.13
Dividend Yield	0.00%
50-Day Moving Average	$16.08
Beta	0.81
Avg. Volume	221,297.65
PE Ratio	-73.38

52-Week High	$23.00
52-Week Low	$11.09
Market Capitalization	$490.22M
EPS (Annual)	-$0.1476
Price to Book	21.20
Revenue Per Employee	$1.26M

ETON
Eton Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ETON News

ETONEton Pharmaceuticals Inc